Trade MBRX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Moleculin Biotech, Inc. (MBRX) is trading at US$0.71, up 5.09% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$11.55M. Over the past 52 weeks, MBRX has traded between US$0.16 and US$15.75. On Syfe you can trade MBRX with $0 commission and add it to your watchlist.
| Previous close | US$0.68 |
|---|---|
| Market cap | US$11.55M |
| 52-week range | US$0.16 – US$15.75 |
| Volume | 762.51K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Moleculin Biotech, Inc.
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.
Year: 2016
Moleculin Biotech Files Registration Statement for Public Offering; Shares Fall
Jul 29, 2:36 PM · MT Newswires
Moleculin Biotech, Inc. (MBRX) stock is trading at US$0.71, +5.09% from the previous close of US$0.68.
The market cap for Moleculin Biotech, Inc. (MBRX) stock is approximately US$11.55M.
The 52-week high for Moleculin Biotech, Inc. (MBRX) stock is US$15.75.
The 52-week low for Moleculin Biotech, Inc. (MBRX) stock is US$0.16.
Moleculin Biotech, Inc. (MBRX) does not currently pay a dividend.
Stay on top of MBRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
